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ImmunocompetentAbstract Coexistence of pulmonary nocardiosis and aspergillosis in a patient of Chronic Obstruc-
tive Pulmonary Disease (COPD) is a diagnostic rarity. They pose a diagnostic challenge due to their
indolent course masquerading as malignancy. Both Aspergillus and Nocardia infections are more
likely to be present in patients who are immune compromised, have structural lung diseases,
especially COPD or a history of surgery or trauma. They carry a high mortality despite timely iden-
tification and management. Here, we report one such rare association of Nocardia and Aspergillus
in an immunocompetent patient of COPD.
 2015 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier
B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).Introduction
Pulmonary infections due to Nocardia and Aspergillus species
in immunocompromised individuals are well established [1,2].
An increased occurrence of infections due to these organisms
in isolation in patients of Chronic Obstructive Pulmonary
Disease (COPD) have been documented in the literature[3,4]. They pose a challenge in diagnosis due to their indolent
course and clinical as well as radiological presentation often
mimicking malignancy. However, coexistence of nocardiosis
and aspergillosis in COPD is rarely reported. We report one
such rare concomitant occurrence of Nocardia and Aspergillus
species in an immunocompetent host with COPD as the only
risk factor.
Case report
A 62 year-old male patient, vegetable vendor by occupation,
presented with a low grade fever, breathlessness and cough with
mucoid expectoration for four days. He denied any history of
chest pain, loss of weight and appetite. He was a previously
diagnosed case of Grade D COPD taking inhaled long acting
bronchodilators as well as steroids and was under regular
follow-up since last three years. The patient also had three exac-
erbations in the last one year despite adequate adherence to
treatment. He was an ex-smoker with 30 pack years of smoking,
who had quit smoking four years back. He denied alcohol and
(a)
(b)
Figure 2 (a and b) High Resolution Computed Tomographic
scan of same patient (mediastinal and lung window respectively)
showing bilateral lower lobe consolidation with air-bronchogram
with centriacinar emphysematous changes.
406 V. Balasubramanian et al.illicit drug use, any history of hypertension or diabetes in the
past and history of exposure to organic or inorganic dust or
other noxious substances. Physical examination revealed tachy-
cardia (120/min), tachypnea (28/min) and was in respiratory
distress with prominent accessory muscles of respiration.
Arterial blood gas analysis revealed type 1 respiratory failure.
Systemic examination revealed vesicular breath sounds with
prolonged expiration and coarse crackles in bilateral infra-
scapular region on auscultation. Blood counts showed leukocy-
tosis (24,000/cm3). Other biochemical analysis reports were
within normal limits. The serology for HIV was negative. The
chest radiograph showed hyperlucent lung fields with bilateral
middle and lower zone air space consolidation (Fig. 1). Patient
was initially admitted to ward and treated for acute exacerba-
tion with oxygen, injectable steroids, inhaled bronchodilators
as well as steroids and empirical course of Piperacillin–
Tazobactam and amikacin. High Resolution Computed Tomo-
graphic (HRCT) thorax revealed emphysematous changes with
bilateral lower lobe consolidation with cavitation (Fig. 2).
Despite the treatment, patient’s clinical condition further dete-
riorated and so was shifted to Intensive Care Unit after twenty-
four hours. Serial chest radiograph revealed progression of
bilateral air space consolidation (Fig. 3). Patient landed into
septic shock as Fractional inspiratory oxygen (FiO2)
requirement increased and needed vasopressor support for
hypotension. Blood and urine cultures were sterile. Sputum
for gram staining showed positive branching filaments sugges-
tive of Nocardia species together with hyaline septate branch-
ing filaments suggestive of Aspergillus species. Further
Lactophenol cotton blue mount of sputum under magnification
40 revealed acute angle branching septate hyphae suggestive
of Aspergillus species (Fig. 4). Ziehl– Neelsen (Z–N) and
Gomori Methanamine Silver (GMS) staining of sputum under
magnification 400 and 1000 respectively revealed long deli-
cate branched filaments that were weakly acid fast positive and
beaded pattern suggestive of Nocardia species (Fig. 5a and b).
These were later confirmed in cultures as Nocardia asteroides
sensitive to trimethoprim–sulfamethoxazole, imipenem,Figure 1 Chest skiagram at presentation showing bilateral
middle as well as lower zone consolidation with cavitation on left
side.
Figure 3 Serial chest skiagram after 3 days of admission
showing progression of bilateral middle as well as lower zone
consolidation extending to upper zones.meropenem, amikacin and gentamicin as well as Aspergillus
fumigatus sensitive to Amphotericin B, Voriconazole and Itra-
conazole. Antibiotics were upgraded to imipenem 500 mg every
Figure 5 (a and b) Ziehl–Neelsen (Z–N) staining and Gomori
Methanamine Silver (GMS) mount of sputum under magnifica-
tion 400 and 1000 respectively showing long delicate branched
filaments that are weakly acid fast and beaded pattern suggestive
of Nocardia species.
Figure 4 Lactophenol cotton blue mount of sputum under
magnification 40 showing acute angle branching septate hyphae
of Aspergillus species.
Pulmonary nocardiosis and aspergillosis in COPD 4076 h and trimethoprim–sulfamethoxazole 480 mg every 8 h to
provide adequate coverage for Nocardia and injectable
Voriconazole was administered for Aspergillus at a dose of
4 mg/kg every 12 h. Despite this, patient’s clinical condition
further deteriorated and patient developed septic shock with
multi-organ failure. Patient was electively intubated and put
on mechanical ventilation in view of worsening clinical status.
Endotracheal aspirate sent for culture confirmed the presenceof A. fumigatus and N. asteroides. Fiber-optic bronchoscopy
revealed no tracheobronchial mucosal abnormality and obvi-
ous endo-bronchial growth. However, same organisms were
isolated on bronchial lavage as sent for culture. Serum as well
as lavage galactomannan levels were negative. After three days
of mechanical ventilation, patient’s clinical condition further
deteriorated requiring high FiO2 requirement and vasopressor
support. The patient eventually succumbed to death despite
of treatment. Post mortem biopsy of lung tissue was sent for
culture and revealed the growth of N. asteroides and A. fumiga-
tus. Concurrent infection with both of these organisms was
established as consistently isolated in sputum, endotracheal
aspirate, bronchoalveolar lavage and postmortem lung tissue.Discussion
Nocardia species is an aerobic branching, filamentous gram
positive, weakly acid-fast bacteria that exists as soil sapro-
phytes. N. asteroides are the most frequent cause of pulmonary
infection in humans among various species with incidence of
85% [5]. Aspergillus species is a saprophytic, aerobic fungus
that develops on dead or decaying organic matter, produces
airborne spores that can be inhaled by man [6] and usually
affects immunocompromised patients but it can develop in
immunocompetent as well [7–9]. Concurrent infection of
Nocardia and Aspergillus though reported in literature is a
rare occurrence. Clinically pulmonary nocardiosis present with
cough with sputum, dyspnea, fever, chest pain and less fre-
quently hemoptysis [10]. In general, the clinical course is
chronic with the duration of symptoms lasting for weeks to
months often masquerading as lung cancer which was similar
to the clinical presentation of our patient [11]. However, pul-
monary aspergillosis has varied manifestation depending on
the host’s immune status or pulmonary structure. The spec-
trum of pulmonary disease ranges from noninvasive disease,
as colonization of organism or the presence of a fungus ball
(aspergilloma), or an allergic response responsible for allergic
bronchopulmonary aspergillosis (ABPA), to semi-invasive or
invasive infections such as chronic necrotizing pneumonia
and invasive pulmonary aspergillosis [12,13]. Both Aspergillus
and Nocardia infections are more likely to present in patients
who are immune compromised such as alcoholism, HIV, pro-
longed steroid use, cancer chemotherapy, solid organ as well as
bone marrow transplantation, have structural lung diseases
such as cystic fibrosis, bronchiectasis, old healed post tubercu-
lar fibro-cavitary disease, COPD or a history of surgery or
trauma. A patient with COPD may have an increased suscep-
tibility to fungal infection for several reasons, as a change in
bronchial architecture, use of steroids, frequent hospitalization
or antibiotic treatments, co-morbidity factors (drug addiction
and diabetes, etc.) [1] and these reasons may be linked to con-
current Aspergillus and Nocardia infections in our patient.
The radiological presentation of pulmonary nocardiosis is
nonspecific. The most common radiological findings are con-
solidations and large irregular nodules. Nodules, cavitary
masses, pleural effusion, pneumothorax, ground-glass opaci-
ties and interstitial patterns can occur as well [14–17]. Invasive
aspergillosis radiologically presents as nodules surrounded by
a halo of ground-glass attenuation (‘‘halo sign”) or pleura-
based, wedge-shaped areas of consolidation. These findings
correspond to hemorrhagic infarcts. In severely neutropenic
408 V. Balasubramanian et al.patients, the halo sign is highly suggestive of angio-invasive
aspergillosis [18]. In a similar case report of concurrent
Nocardia and Aspergillus in a patient with old tubercular
cavity, Contrast Enhanced Computed Tomography (CECT)
thorax revealed a soft tissue density mass with speculated mar-
gins and satellite nodular specks in the right lower lobe [19].
Patient presented with areas of ground glassing and consolida-
tion with cavitation in present case. The diagnosis should
always be based on isolation of Nocardia spp. in respiratory
secretions. Previous study has found sputum cultures to be
positive in 90% of the present patients, and in 100% when
bronchoalveolar lavage was performed. Nocardia species is a
slowly growing microorganism that requires a prolonged per-
iod of incubation. Cultures should be maintained for at least
3 weeks before being discarded as negative [20]. Sputum, endo-
tracheal samples for direct microscopy and culture showed the
presence of gram positive branching hyphae suggestive of
Nocardia and hyaline septate branching hyphae suggestive of
Aspergillus. The sputum and endotracheal secretions for mod-
ified Z–N stain showed the presence of weakly positive acid
fast bacilli further supporting the presence of Nocardia.
Treatment of nocardiosis usually involves a sulfonamide
containing regimen such as trimethoprim–sulfamethoxazole
(TMP–SMX). Other alternatives are amikacin, imipenem
[21–23], third-generation cephalosporins, minocycline, netilmi-
cin and amoxicillin–clavulanic. Experimental studies have
shown in vitro synergy with imipenem–cefotaxime, cefo-
taxime–amikacin and imipenem–amikacin with good clinical
results [24,25]. Voriconazole is a potent new antifungal com-
pound that is efficacious in a significant proportion of patients
with aspergillosis. It is most efficacious as primary therapy for
invasive aspergillosis [26]. However in the present case intra-
venous imipenem, Voriconazole and oral TMP–SMX were
not successful and patient succumbed to death reason could
be rapid progression of the disease. Pulmonary nocardiosis is
associated with very high mortality, ranging from 14% to
40% [27], increasing to 60–100% when dissemination to the
central nervous system (CNS) occurs. So a coexistent infection
is expected to have a significant morbidity and mortality and in
this case despite timely diagnosis and appropriate intervention,
patient died due to sepsis induced multi-organ dysfunction
syndrome.
Though occurrence of nocardiosis and aspergillosis in
immunocompromised subjects are well established, they should
be kept as a part of differential work up in immunocompetent
patients with COPD as the only risk factor. Both infections
pose a diagnostic challenge to clinicians masquerading as
malignancy or pulmonary tuberculosis due to the indolent
course of illness and radiological presentation. The concurrent
existence of Aspergillus and Nocardia deserves special atten-
tion as both infections are associated with significant morbidity
and mortality requiring timely diagnosis and management.Conflict of interest
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